Picture of Torrent Pharmaceuticals logo

TORNTPHARM — Torrent Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Torrent Pharma misses Q2 profit view after closure of insulin unit

Oct 25 (Reuters) - India's Torrent Pharmaceuticals  TORP.NS  reported a smaller-than-expected second-quarter
profit on Friday, hurt by the shutdown of an insulin manufacturing facility. 
    The Ahmedabad, Gujarat-based company reported a 17.4% rise in consolidated net profit to 4.53 billion rupees
(nearly $54 million) for the quarter ended Sept. 30, missing analysts' estimates of 4.97 billion rupees, per data
compiled by LSEG. 
    Torrent, known for its calcium supplement Shelcal 500, manufactures drugs to treat diabetes, cancer and
infections.
        The revenue of its core segment, which treats chronic diseases, jumped 14%, boosting total revenue by 8.6% to
28.31 billion rupees. 
  
    
    KEY CONTEXT 
    Indian drugmakers, such as Torrent Pharma and peer Mankind Pharma  MNKI.NS , continue to benefit from steady
domestic demand for their specialty drugs and those used to treat chronic illnesses.
    However, Torrent Pharma's sales were hurt during the quarter due to the closure of an insulin manufacturing
facility in August, it said. 
    Diabetes is a significant contributor to the company's portfolio, but it does not specify the share of these
drugs in overall revenue. 
        The company expects to recover the shortfall in revenue in the fourth quarter, it said.
  

    
    PEER COMPARISON
    
                                                   Estimates (next 12           Analysts' sentiment          
                                                        months)                                              
                     RIC        PE      EV/EBIT  Revenue      Profit     Mean       # of      Stock to       Div
                                        DA       growth (%)   growth     rating*    analysts  price          yield
                                                              (%)                             target**       (%)
 Torrent              TORP.NS    47.34    27.07     12.63       28.23    Buy              27      1.01           0.84
 Pharmaceuticals                                                                                             
 Ltd                                                                                                         
 Mankind Pharma Ltd   MNKI.NS    42.04    29.45     14.61       16.87    Buy              15      1.03       NULL
 Glenmark             GLEN.NS    29.64    16.97     13.15      235.70    Buy              10      1.09           0.15
 Pharmaceuticals                                                                                             
 Ltd                                                                                                         
 Sun Pharmaceutical   SUN.NS     36.45    27.12     10.54       14.97    Buy              31      1.01           0.73
 Industries Ltd                                                                                              
 * Mean of analysts' ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell
 ** Ratio of the stock's last close to analysts' mean price target; a ratio above 1 means the stock is trading above
the PT  
     
    JULY TO SEPTEMBER STOCK PERFORMANCE  
 -- All data from LSEG
 -- $1 = 84.0570 Indian rupees

    <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
JULY TO SEPTEMBER STOCK PERFORMANCE    https://tmsnrt.rs/3Uo31w1
    ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
 (Reporting by Kashish Tandon in Bengaluru; Editing by Sonia Cheema)
 ((Kashish.Tandon@thomsonreuters.com; 8800437922;))

Recent news on Torrent Pharmaceuticals

See all news